IP Library Granted Patent US 11,707,617
Granted Patent B2
US 11,707,617 · App. 17/095,096 · Granted Jul 25, 2023

Method to extract and quantify the cardiac end diastolic point/mitral valve closing point from the HVAD estimated flow waveform

Inventors: Carlos Reyes (Davie, FL); Neethu Lekshmi Vasudevan Jalaja (Miami Lakes, FL)
Assignee: HeartWare, Inc.
A61M60/538A61M60/148A61M60/422A61M2205/18A61M2205/3331A61M2230/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,707,617
App. No.
17/095,096
Granted
Jul 25, 2023
Kind
B2
Abstract

A control circuit for a sensorless implantable blood pump configured to determine mitral valve regurgitation includes processing circuitry configured to generate an estimated blood flow waveform from the sensorless implanted blood pump and generate an alert if between an end period of diastole and a beginning period of systole a measured amplitude of the estimated blood flow waveform does not include an inflection point.

Claims (33)

1. A control circuit for a sensorless implantable blood pump configured to determine mitral valve regurgitation, the control circuit comprising:

processing circuitry configured to:

generate an estimated blood flow waveform from the sensorless implanted blood pump; and

generate an alert if between an end period of diastole and a beginning period of systole a measured amplitude of the estimated blood flow waveform does not include an inflection point.

2. The control circuit of claim 1 , wherein the estimated blood flow waveform is based on current supplied to the sensorless implanted blood pump.

3. The control circuit of claim 1 , wherein the sensorless implanted blood pump is a ventricular assist device.

4. The control circuit of claim 1 , wherein the sensorless implanted blood pump is a centrifugal pump.

5. The control circuit of claim 1 , wherein the sensorless implanted blood pump is electrically coupled to at least one from the group consisting of an implanted controller and an external controller.

6. The control circuit of claim 1 , wherein the control circuit is further configured to periodically measure the amplitude of the estimated blood flow between an end period of diastole and a beginning period of systole.

7. The control circuit of claim 1 , wherein an absence of the inflection point is indicative of mitral valve regurgitation.

8. The control circuit of claim 1 , wherein the generated alert includes a prompt to adjust the speed of the sensorless implanted blood pump.

9. A control circuit for a sensorless implantable blood pump, the control circuit comprising:

processing circuitry configured to:

generate at least one from the group consisting of an estimated current waveform and flow waveform from the sensorless implanted blood pump;

determine a mitral valve closing point from the estimated at least one from the group consisting of current waveform and flow waveform from the sensorless implanted blood pump;

calculate a preload relative indicator;

compare the preload relative indicator with a normal baseline preload relative indicator; and

adjust the speed of the pump based on the comparison.

10. The control circuit of claim 9 , wherein the processing circuitry is configured to calculate the preload relative indicator by dividing a measured amplitude between the mitral valve closing point and a trough of the estimated at least one from the group consisting of current waveform and flow waveform by a measured amplitude between a peak of the at least one from the group consisting of current waveform and flow waveform and the trough.

11. The control circuit of claim 9 , wherein the sensorless implanted blood pump is a ventricular assist device.

12. The control circuit of claim 9 , wherein the sensorless implanted blood pump is a centrifugal pump.

13. The control circuit of claim 9 , wherein the processing circuitry is configured to generate an alert if the preload relative indicator deviates from the normal baseline preload relative indicator by a predetermined percentage.

14. The control circuit of claim 9 , wherein the processing circuitry is configured to increase the speed of the pump if the preload relative indicator is greater than the normal baseline preload relative indicator by a predetermined percentage.

15. The control circuit of claim 14 , wherein the predetermined percentage is between 5-15%.

16. The control circuit of claim 9 , wherein the processing circuitry is configured to decrease the speed of the pump if the preload relative indicator is less than the normal baseline preload by a predetermined percentage.

17. The control circuit of claim 16 , wherein the predetermined percentage is between 5-15%.

18. A control circuit for a sensorless implantable blood pump, the control circuit comprising:

processing circuitry configured to:

generate at least one from the group consisting of an estimated current waveform and flow waveform from the sensorless implanted blood pump;

determine a mitral valve closing point from the estimated at least one from the group consisting of current waveform and flow waveform from the sensorless implanted blood pump;

calculate a preload relative indicator by dividing a measured amplitude between the mitral valve closing point and a trough of the estimated at least one from the group consisting of current waveform and flow waveform by a measured amplitude between a peak of the at least one from the group consisting of current waveform and flow waveform and the trough;

compare the preload relative indicator with a normal baseline preload; and

generate an alert if the preload relative indicator deviates from the normal baseline preload by a between 5-15%.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 19, 2024
From: HEARTWARE, INC.
To: BOSTON SCIENTIFIC SCIMED, INC.
Reel/Frame 069520/0137 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 11, 2020
From: REYES, CARLOS; VASUDEVAN JALAJA, NEETHU LEKSHMI
To: HEARTWARE, INC.
Reel/Frame 054336/0068 →
Continuity (2)
Provisional Application 62939158 · Nov 22, 2019
Related Publication 20210154384A1 · May 27, 2021
Cited By (17)
US 12,194,287 US 12,201,821 US 12,222,267 US 12,257,424 US 12,268,862 US 12,310,708 US 12,311,160 US 12,324,906 US 12,377,256 US 12,478,267 US 12,491,357 US 12,508,418 US 12,569,671 US 12,576,261 US 12,667,714 US 12,702,816 US 12,702,821